SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-019504
Filing Date
2021-04-20
Accepted
2021-04-20 07:22:54
Documents
13
Period of Report
2021-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20210416.htm   iXBRL 8-K 52095
2 EX-99.1 crsp-ex991_6.htm EX-99.1 32843
  Complete submission text file 0001564590-21-019504.txt   222510

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crsp-20210416.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20210416_lab.xml EX-101.LAB 18642
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20210416_pre.xml EX-101.PRE 11151
6 EXTRACTED XBRL INSTANCE DOCUMENT crsp-8k_20210416_htm.xml XML 3398
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 21836287
SIC: 2836 Biological Products, (No Diagnostic Substances)